Children in need of Pharmacare: Medication funding requests at the Toronto Hospital for Sick Children

Canadian Journal of Public Health

Volumn 94, Issue 2, 2003, Pages 121-126

  Ungar, Wendy J ^a,b   Daniels, Carolyn ^a   McNeill, Ted ^a   Seyed, Mahdie ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG;

ARTICLE; CHILD; CHILD CARE; CHILDHOOD CANCER; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; DRUG USE; EMPLOYMENT; FAMILY LIFE; FEMALE; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RESEARCH; NEUROLOGIC DISEASE; ORGAN TRANSPLANTATION; OUTPATIENT; PEDIATRIC HOSPITAL; PHARMACEUTICAL CARE; RETROSPECTIVE STUDY; SOCIAL STATUS; SOCIAL WORK; STATISTICAL ANALYSIS; TIME; CANADA; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HOSPITAL; HOSPITAL PHARMACY; MEDICAL CARE; ORGANIZATION AND MANAGEMENT; PATIENT; PUBLIC HEALTH; SOCIAL CLASS; UTILIZATION REVIEW;

CHILD; FINANCING, ORGANIZED; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HOSPITALS, PEDIATRIC; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAL ASSISTANCE; MEDICALLY UNINSURED; NATIONAL HEALTH PROGRAMS; ONTARIO; PHARMACY SERVICE, HOSPITAL; PROGRAM EVALUATION; PUBLIC SECTOR; RETROSPECTIVE STUDIES; SOCIAL CLASS;

EID: 0037363027     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404584     Document Type: Article

References (18)

1. Health Canada. National Forum on Health Synthesis Reports and Issues Papers - Final Report - Volume II. Canada Health Action: Building on the Legacy Directions for a Pharmaceutical Policy in Canada. Ottawa, ON: Health Canada, 1997. Available on-line at: http://wwwnfh.hc-sc.gc.ca/publicat/finvol2/pharm/idxphar.htm
2. Health Canada. Canadians' access to insurance for prescription medicines. Applied Management in association with Fraser Group Tristat Resources. Health Canada, March 2000. Available on-line at: http://www.hc-sc.gc.ca/english/care.htm#Pharma
3. Jacobs P, Bachynsky J. Public Policies Related to Drug Formularies in Canada: Economic Issues. Edmonton, AB: Institute of Health Economics, 2000. Working Paper 00-2:1-51.
4. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-29.
5. Anis AH. Pharmaceutical policies in Canada: Another example of federal-provincial discord. CMAJ 2000;162:523-26.
6. Levy RA. Prescription cost sharing, economic and health impacts and implications for health policy. PharmacoEconomics 1992;2:219-37.
7. Reeder CE, Lingle EW, Schulz RM, Mauch RP, Nightengale BS, Pedersen CA, et al. Economic impact of cost-containment strategies in third party programmes in the US (Part I). Pharmacoeconomics 1993;4:92-103.
8. Hurley J, Arbuthnot Johnson N. The effects of co-payments within drug reimbursement programs. Canadian Public Policy 1991;17:473-89.
9. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin TJ. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-77.
10. Ungar WJ, Coyte PC, Chapman KR, MacKeigan L, The Pharmacy Medication Monitoring Program Advisory Board. The patient level cost of asthma in adults in south central Ontario. Can Respir J 1998;5:463-71.
11. Ungar WJ, Coyte PC, The Pharmacy Medication Monitoring Program Advisory Board. Prospective study of the patient-level cost of asthma care in children. Ped Pulmonol 2001;32:101-8.
12. Ungar WJ, Santos MT, Poston JW, Goldsmith CH, Levine MAH, Willison DJ, et al. The impact of drug plan access on health outcomes in children with asthma. [abstract] Can J Clin Pharmacol 2000;7:72.
13. Hong S, Shepherd MD. Outpatient prescription drug use by children enrolled in five drug benefit plans. Clin Ther 1996;18:528-45.
14. Mustard CA, Frohlich N. Socioeconomic status and the health of the population. Med Care 1995;33:DS43-DS54.
15. Katz SJ, Hofer TP, Manning WG. Physician use in Ontario and the United States: The impact of socioeconomic status and health status. Am J Public Health 1996;86:520-24.
16. Halfon N, Newacheck PW. Childhood asthma and poverty: Differential impacts and utilization of health services. Pediatrics 1993;91:56-61.
17. Ortega AN, Gergen PJ, Paltiel D, Bauchner H, Belanger K, Leaderer BP. Impact of site of care, race, and Hispanic ethnicity on medication use for childhood asthma. Pediatrics 2002;109(1):e1-6.
18. Weineck RB, Weigers ME, Cohen JW. Children's health insurance, access to care, and health status: New findings. Health Affairs 1998;17:127-36.